News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
109,853 Results
Type
Article (6545)
Company Profile (32)
Press Release (103276)
Section
Business (28664)
Career Advice (165)
Deals (4534)
Drug Delivery (13)
Drug Development (13950)
Employer Resources (8)
FDA (3533)
Job Trends (2556)
News (50753)
Policy (3897)
Tag
Academia (694)
Alliances (9748)
Alzheimer's disease (208)
Antibody-drug conjugate (ADC) (18)
Approvals (3530)
Artificial intelligence (37)
Bankruptcy (24)
Best Places to Work (2377)
Biotechnology (25)
Breast cancer (50)
Cancer (330)
Cardiovascular disease (26)
Career advice (145)
Cell therapy (66)
Clinical research (10718)
Collaboration (137)
COVID-19 (304)
C-suite (18)
Data (299)
Diabetes (20)
Diagnostics (1488)
Earnings (9203)
Events (13732)
Executive appointments (57)
FDA (3689)
Funding (82)
Gene editing (20)
Gene therapy (54)
GLP-1 (104)
Government (465)
Healthcare (3589)
Infectious disease (314)
Inflammatory bowel disease (37)
Interviews (26)
IPO (1820)
Job creations (259)
Job search strategy (126)
Layoffs (30)
Legal (449)
Liver cancer (25)
Lung cancer (40)
Manufacturing (64)
Medical device (2672)
Medtech (2672)
Mergers & acquisitions (2766)
Metabolic disorders (74)
Neuroscience (240)
NextGen Class of 2024 (1231)
Non-profit (524)
Northern California (251)
Obesity (44)
Opinion (18)
Patents (19)
People (7506)
Phase I (3697)
Phase II (5056)
Phase III (3230)
Pipeline (104)
Postmarket research (238)
Preclinical (1977)
Radiopharmaceuticals (78)
Rare diseases (44)
Real estate (909)
Regulatory (3215)
Research institute (564)
Series A (20)
Southern California (234)
Startups (557)
United States (2781)
Vaccines (45)
Weight loss (23)
Date
Today (5)
Last 7 days (16)
Last 30 days (400)
Last 365 days (6765)
2024 (6765)
2023 (7610)
2022 (10564)
2021 (10745)
2020 (9749)
2019 (8204)
2018 (6307)
2017 (6201)
2016 (5722)
2015 (6267)
2014 (4228)
2013 (3581)
2012 (3832)
2011 (3867)
2010 (3191)
Location
Africa (88)
Arizona (27)
Asia (5963)
Australia (1058)
California (578)
Canada (247)
China (46)
Colorado (61)
Connecticut (23)
Europe (14378)
Florida (112)
Georgia (38)
Idaho (18)
Illinois (65)
Indiana (73)
Maryland (96)
Massachusetts (552)
Michigan (43)
Minnesota (65)
New Jersey (199)
New York (170)
North Carolina (190)
Northern California (251)
Ohio (50)
Pennsylvania (146)
South America (132)
Southern California (234)
Texas (135)
Washington State (59)
109,853 Results for "tissue analytics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Springbok Analytics Announces Phase 1 Clinical Trial Evaluating Clenbuterol as FSHD Treatment
Springbok Analytics (www.springbokanalytics.com), a life sciences muscle analytics company, announced today its participation in a Phase 1 Clinical Trial to evaluate safe dosage for clenbuterol as a treatment for Facioscapulohumeral muscular dystrophy (FSHD).
June 12, 2024
·
4 min read
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
Axogen, Inc. announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing.
June 24, 2024
·
6 min read
Press Releases
Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics
November 6, 2024
·
2 min read
Press Releases
Adela to Present Biological Insights into its Tissue-Agnostic Assay for Molecular Residual Disease Detection at the AACR Special Conference in Cancer Research
November 15, 2024
·
3 min read
Biotech Bay
Adela to Present Data from Tissue-Agnostic MRD Assay at the American Association for Cancer Research Annual Meeting 2024
Adela, Inc. today announced data will be presented at the American Association for Cancer Research (AACR) Annual Meeting from April 5-10, 2024 from its tissue-agnostic minimal residual disease (MRD) assay.
March 19, 2024
·
3 min read
Press Releases
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
December 19, 2024
·
3 min read
Biotech Bay
Adela to Present Data Supporting Use of its Tissue-Agnostic MRD Assay for Recurrence Prediction and Monitoring in Patients with Head & Neck Cancer at the American Society of Clinical Oncology 2024 Meeting
Adela, Inc will present results demonstrating the ability of its tissue-agnostic MRD assay to predict recurrence in head & neck cancer, during an Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 3, 2024.
May 30, 2024
·
4 min read
Press Releases
MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification
Tozaro’s rationally designed smart polymer affinity reagents offer novel analytics and purification solutions to enhance the development and manufacture of viral vectors in cell and gene therapy Rebrand follows Series A funding round in February 2024
August 5, 2024
·
2 min read
Press Releases
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
December 9, 2024
·
8 min read
Press Releases
Brinter AM Technologies will provide a 3D bioprinter for Advanced Tissue Manufacturing capabilities at the International Space Station (ISS) for an ESA project.
With a commitment to foster space exploration and terrestrial benefits through human spaceflight activities, ESA is investigating microgravity’s effects on human tissue to develop solutions that keep astronauts healthy during long-term missions and improve Life on Earth.
August 29, 2024
·
3 min read
1 of 10,986
Next
